Citations

Showing 10 of 108094 citations.

Sex‐Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial
Madan, Mina , Abbott, J. Dawn , Lennon, Ryan J. , So, Derek , MacDougall, Andrea, McLaughlin, Mary Ann , Murthy, Vishakantha , Saw, Jacqueline , Rihal, Charanjit S. , Farkouh, Michael E. , Pereira, Naveen L. , Abdul‐Nour, Khaled, Dehghani, Payam , Doll, Josh, El‐Hajjar, Mohammed, Ginete, Wilson , Bachuwar, Alok, Graham, John, Guild, Cameron, Campbell, William W., Kostopoulis, Louie, Lane, Gary E. , Marzo, Kevin , O’Cochlain, Fearghas, Overgaard, Christopher B., Dzavik, Vlad, Raveendran, Ganesh , Reimers, Carl D., Garratt, Kirk N. , Saucedo, Jorge , Levisay, Justin , Suresh, D. P., Sweeney, John P., Tiong, Irving, Weitz, Steven, Wu, Alan H.B. , Lennon, Ryan J , So, Derek Y , Rihal, Charanjit S. , Goodman, Shaun G , Dawn Abbott, J , Goodman, Shaun G. , Abdul-Nour, Khaled, Darki, Amir , El-Hajjar, Mohammed C., Escobedo, Jorge , Frank, Adam, Goldberg, Ronald B , Campbell, William, Kim, Sang‐Wook , Lim, Hong‐Seok , Nazif, Tamim , Džavík, Vladimír , Razzouk, Louai , Reimers, Carl, Suresh, D.P., Weitz, Steven

Mayo Clinic

Journal of the American Heart Association | June 14, 2022 | Volume: 11 | Issue: 12 | Pages: No page available

10.1161/jaha.121.024709 | PMID 35699175 Get It

Background TAILOR‐PCI (Tailored Antiplatelet Initiation to Lessen Outcomes due to decreased Clopidogrel Response After Percutaneous Coronary Intervention) studied genotype‐guided selection of antiplatelet therapy after percutaneous coronary intervention versus conventional therapy with clopidogrel. The presence of CYP2C19 loss‐of‐function alleles in patients treated with clopidogrel may be associated with increased risk for ischemic events. We report a prespecified sex‐specific analysis of genotyping and associated cardiovascular outcomes from this study. Methods and Results Associations between sex and major adverse cardiac events (MACE: cardiovascular death, myocardial infarction, stroke, stent thrombosis, and severe recurrent ischemia) and Bleeding Academic Research Consortium (BARC) bleeding at 12 months were analyzed using Cox proportional‐hazards models. Among 5276 randomized patients, loss‐of‐function carriers were observed in ≈36% of both sexes, and >80% of carriers were heterozygotes. At 12 months, after adjustment for baseline differences, risks of MACE (HR , 1.28 [0.97 to 1.68]; P =0.088) and BARC bleeding (hazard ratio [HR], 1.36 [0.91 to 2.05]; P =0.14) were comparable among women and men. There were no significant interactions between sex and treatment strategy for MACE interaction P value ( P int =0.59) or BARC bleeding ( P int =0.47) nor for sex and genotype (MACE P int =0.15, and BARC bleeding P int =0.60). Conclusions CYP2C19 loss‐of‐function alleles were present in ≈1 in 3 women and men. Women had similar adjusted risks of MACE and bleeding as men following percutaneous coronary intervention. Genotype‐guided therapy did not significantly reduce the risk of MACE or bleeding relative to conventional therapy for both sexes. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01742117.
INVESTIGATING THE QUALITY OF MACHINE LEARNING RESEARCH AND REPORTING IN HYPERTENSION
Lip, Stefanie , Manandhar, Ishan , Pattnaik, Harsha , Alsanosi, Safaa , Sionakidis, Aristeidis , Le, Nhu Ngoc , Mehta, Dhruven , Kassi, Maria, Rostron, Maggie , Tummala, Ramakumar, Joe, Bina , Alsanosi, Safaa , Toit, Clea du , Tran, Tran , Aryal, Sachin , Sykes, Robert , Deo, Neha , McCallum, Linsay , Stevenson, Leah, Kashyap, Rahul , Padmanabhan, Sandosh

Mayo Clinic

Journal of Hypertension | June 14, 2022 | Volume: 40 | Issue: Suppl 1 | Pages: e78

10.1097/01.hjh.0000835956.81410.5e Get It

Objective: Artificial intelligence and machine learning (AI/ML) are increasingly being applied to big clinical data to tackle research questions that cannot be answered with traditional statistical methods. The field is still in its nascent stages and there is a paucity of guidelines for conducting and reporting AI/ML research in hypertension. The objective was to apply the HUMANE checklist to survey the present landscape of AI/ML in hypertension to inform the development of hypertension-specific guidelines and recommendations. Design and method: The HUMANE checklist was developed by global clinical and AI/ML experts through the Delphi method. It assesses the quality of medical AI/ML articles based on whether they cover subjects expected in any peer-reviewed, clinical or AI/ML research publication. A cooping review was carried out to identify articles presenting original research in AI/ML and hypertension published in 2019–2021. Two independent reviewers applied the checklist to each article and in the case of discordance, the response was adjudicated by an AI/ML expert. Results were analysed to assess compliance with the survey (% of papers satisfying checklist requirements). Results: A total of 63 manuscripts was reviewed. A summary of results is shown in Figure 1. Highest compliance was seen for items relating to general article presentation, with compliance ranging from 68% to 98% (description of statistical analysis methods and background context, respectively). Lowest compliance was seen with checklist items relating to clinical research and AI/ML methods. 44% of reviewed articles described the demographics of their dataset and 48% stated their inclusion/exclusion criteria. Nonetheless, datasets were deemed appropriate for investigative aims in 93% of articles. 30% of manuscripts reported their calibration measures, while 73% stated their performance metrics. Internal validation was carried out in 75% of studies, but external validity was assessed in only 14% of cases. Algorithmic bias was addressed in 11% of papers. Conclusions: Application of AI/ML methods in hypertension research is growing, but the majority of current work has major shortfalls in reporting quality, model validation and algorithmic bias. Our study identifies areas of improvement to enable the full realisation of the potential of AI/ML in hypertension.
Acute Ischemic Stroke Presentation Masked by Falsely Localizing Motor Seizure: A Clinical Case Series
Weil, Erika L. , Stitt, Derek , Cascino, Gregory D. , Nasr, Deena M. , Stitt, Derek W, Rabinstein, Alejandro A.

Mayo Clinic

The Neurohospitalist | June 14, 2022 | Volume: 12 | Issue: 4 | Pages: 647-650

10.1177/19418744221108555 | PMID 36147759 Get It

In this case series, we describe a novel observation in which 4 patients with acute ischemic stroke secondary to large vessel occlusion and no history of seizure present with focal seizure activity localizable to a chronic, contralateral infarct. The explanation for this phenomenon is unknown but may be due to a combination of effects involving disrupted interhemispheric inhibitory connections and epileptogenic changes involving chronically infarcted tissue.
Collaborative biostatistics and epidemiology in academic medical centres: A survey to assess relationships with health researchers and ethical implications
Devick, Katrina L. , Gunn, Heather , Perkins, Susan M. , Schulte, Phillip J. , Gunn, Heather J., Enders, Felicity T, Gunn, Heather , Price, Lori Lyn , Meinzen‐Derr, Jareen K. , Enders, Felicity

Mayo Clinic

Stat | June 14, 2022 | Volume: 11 | Issue: 1 | Pages: No page available

10.1002/sta4.481 | PMID 37635749 Get It

AbstractThe role of collaborative biostatisticians and epidemiologists in academic medical centres and how their degree type, supervisor type and sex influences recognition and feelings of respect is poorly understood. We conducted a cross‐sectional survey of self‐identified biostatisticians and epidemiologists working in academic medical centres in the United States or Canada. The survey was sent to 341 contacts at 125 institutions who were asked to forward the survey invitation to faculty and staff at their institution and posted on Community sections of the American Statistical Association website. Participants were asked a variety of questions including if they felt pressured to produce specific results, whether they had intellectual and ethical freedom to pursue appropriate use of statistical methods in collaborative research and if they felt their contributions were appropriately recognized by collaborators. We received responses from 314 biostatisticians or related methodologists. A majority were female (59%), had a doctorate degree (52%) and reported to a statistician or biostatistician supervisor (69%). Overall, most participants felt valued by their collaborators, but that they did not have sufficient calendar time to meet deadlines. Doctoral‐level participants reported more autonomy in their collaborations than master's level participants. Females were less likely to feel recognized and respected compared with males. The survey results suggest that while most respondents felt valued by their collaborators, they have too many projects and need more time to critically review research. Further research is needed to understand why response differs by sex and how these responses fluctuate over time.
Esthesioneuroblastoma as a cause of syndrome of inappropriate antidiuretic hormone
Zhang, Wynne Q., Glaun, Mica , Jalali, Ali , Samson, Susan L. , Gallagher, K. Kelly

Mayo Clinic

Acta Oto-Laryngologica Case Reports | June 14, 2022 | Volume: 7 | Issue: 1 | Pages: 19-21

10.1080/23772484.2022.2043752 Get It

Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons
Tulledge‐Scheitel, Sidna M. , Pike, Marsha L., O’Brien, M D , Razonable, Raymund R. , Shah, Aditya , Challener, Douglas W. , Tulledge-Scheitel, Sidna M, O'Brien, Michael, Razonable, Raymund R , Shah, Aditya S , Ranganath, Nischal , O’Horo, John C. , O’Brien, Michael

Mayo Clinic

Clinical Infectious Diseases | June 14, 2022 | Volume: 76 | Issue: 3 | Pages: e537-e539

10.1093/cid/ciac481 | PMID 35698452 Get It

Abstract In a cohort of 483 high-risk patients treated with nirmatrelvir/ritonavir for COVID-19, 2 patients (0.4%) required hospitalization by day 30. Four patients (0.8%) experienced rebound of symptoms, which were generally mild, at a median of 9 days after treatment, and all resolved without additional COVID-19–directed therapy.
Complications of Endobronchial Valve Placement for Bronchoscopic Lung Volume Reduction
Swanson, Karen L., Lee, Justin Z. , Tan, Min Choon , Cartin‐Ceba, Rodrigo , Sakata, Kenneth K. , Maldonado, Fabien , Tan, Min C , Low, See‐Wei

Mayo Clinic

Journal of Bronchology & Interventional Pulmonology | June 14, 2022 | Volume: 29 | Issue: 3 | Pages: 206-212

10.1097/lbr.0000000000000859 | PMID 35698284 Get It

Background: Patients with advanced emphysema experience breathlessness due to impaired respiratory mechanics and diaphragm dysfunction. Bronchoscopic lung volume reduction (BLVR) is a minimally invasive bronchoscopic procedure done to reduce hyperinflation and air trapping, promoting atelectasis in the targeted lobe and allowing improved respiratory mechanics. Real-world data on safety and complications outside of clinical trials of BLVR are limited. Methods: We queried the US Food and Drug Administrations (FDA) Manufacturers and User Device Experience database from May 2019 to June 2020 for reports involving BLVR with endobronchial valve (EBV) placement. Events were reviewed for data analysis. Results: We identified 124 cases of complications during BLVR with EBV implantation. The most-reported complication was pneumothorax (110/124, 89%), all of which required chest tube placement. A total of 54 of these cases (54/110, 49%) were complicated by persistent air leak requiring additional interventions. Repeat bronchoscopy was needed to remove the valves in 28 patients, 12 were discharged with a Heimlich valve, and 10 had an additional pleural catheter placed. The other complications of BLVR with EBV placement included respiratory failure (6/124, 5%), pneumonia (4/124, 3%), hemoptysis (2/124, 1.6%), valve migration (1/124, 1%), and pleural effusion (1/124, 1%). A total of 14 deaths were reported during that year. Conclusion: Pneumothorax is the most-reported complication for BLVR with EBV placement, and in 65% of cases, pneumothorax is managed without removing valves. Importantly, 14 deaths were reported during that timeframe. Further studies are needed to estimate the true magnitude of the complications associated with BLVR.
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants
Lopez-Medina, Ana I , Chahal, C. Anwar A. , Luzum, Jasmine A. , Chahal, Choudhary Anwar A , Luzum, Jasmine A

Mayo Clinic

Pharmacogenomics | June 14, 2022 | Volume: 23 | Issue: 9 | Pages: 543-557

10.2217/pgs-2022-0027 | PMID 35698903 Get It

Is There Clinically Relevant Plasma Interference with ELISA Detection of APS Antibodies? Reproducibility of Real-World Paired Serum and Plasma Testing
Pham, Michael M. , Orsolini, Giovanni , Crowson, Cynthia S. , Snyder, Melissa R. , Pruthi, Rajiv K. , Moder, Kevin G.

Mayo Clinic

Thrombosis and Haemostasis | June 13, 2022 | Volume: 122 | Issue: 11 | Pages: 1948-1950

10.1055/a-1874-8548 | PMID 35697257 Get It

Frequency of Asymptomatic Optic Nerve Enhancement in a Large Retrospective Cohort of Patients With Aquaporin-4+ NMOSD
Morris, Pearse , Buciuc, Marina , Tajfirouz, Deena , Wingerchuk, Dean M. , Weinshenker, Brian G. , Eggenberger, Eric , Nome, Marie A. Di , Pittock, Sean J. , Bhatti, M. Tariq , Chen, John J. , Shah, Shailee S, Buciuc, Marina , Tajfirouz, Deena , Wingerchuk, Dean M , Weinshenker, Brian G , Eggenberger, Eric R, Di Nome, Marie, Pittock, S J , Chen, John J , Shah, Shailee , Flanagan, Eoin P.

Mayo Clinic

Neurology | June 13, 2022 | Volume: 99 | Issue: 8 | Pages: No page available

10.1212/wnl.0000000000200838 | PMID 35697504 Get It